Literature DB >> 23418376

Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years.

Lennart Bertilsson1, Boel Andersson-Gäre, Anders Fasth, Ingemar F Petersson, Helena Forsblad-D'elia.   

Abstract

OBJECTIVE: To investigate disease course, outcome, and predictors of outcome in an unselected population-based cohort of individuals diagnosed with juvenile chronic arthritis (JCA) followed for 17 years.
METHODS: The cohort consisted of 132 incidence JCA cases identified 1984-1986 according to EULAR criteria. At 5-year followup, 129 individuals underwent joint assessment, laboratory measurements, radiographic examination, and medication and functional assessment. At 17-year followup, 86 were examined with joint assessment, laboratory measurements, medication assessment, Health Assessment Questionnaire (HAQ), Keitel functional test (KFT), and Medical Outcomes Study Short Form-36 (SF-36).
RESULTS: At 17-year followup, 40% were in remission, 44% changed subgroups, median HAQ score was 0.0 (range 0.0-1.5), and median KFT was 100 (range 54-100). SF-36 scores were significantly lower compared to a reference group. Thirty-nine percent of those in remission at 5-year followup were not in remission at 17-year followup. In multivariate analyses of variables from the 17-year followup: remission was predicted by remission at 5-year followup (OR 4.8); HAQ > 0 by rheumatoid factor (RF)-positivity at 5-year followup (OR 3.6); KFT < 100 by nonremission (OR 11.3); and RF-positivity (OR 5.6) at 5-year followup; and the SF-36 physical component summary score above average of the reference group by remission at 5-year followup (OR 5.8).
CONCLUSION: This longterm study of 86 individuals with JCA showed large variability of disease courses and of impaired health-related quality of life. Sixty percent were not in remission at 17-year followup. Longterm outcome was best predicted by and associated with characteristics at 5-year followup rather than those at onset.

Entities:  

Keywords:  JUVENILE CHRONIC ARTHRITIS; JUVENILE IDIOPATHIC ARTHRITIS; JUVENILE RHEUMATOID ARTHRITIS; OUTCOME ASSESSMENT; PROGNOSIS

Mesh:

Substances:

Year:  2013        PMID: 23418376     DOI: 10.3899/jrheum.120602

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  30 in total

Review 1.  Improving care delivery and outcomes in pediatric rheumatic diseases.

Authors:  Julia G Harris; Catherine A Bingham; Esi M Morgan
Journal:  Curr Opin Rheumatol       Date:  2016-03       Impact factor: 5.006

2.  Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study.

Authors:  J H Anderson; K R Anderson; H A Aulie; C S Crowson; T G Mason; S P Ardoin; A M Reed; B Flatø
Journal:  Scand J Rheumatol       Date:  2016-02-08       Impact factor: 3.641

Review 3.  [Transition from pediatric to adult rheumatological care].

Authors:  K Minden; S Schalm
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

Review 4.  Clinical Outcome and Long-term Remission in JIA.

Authors:  Mia Glerup; T Herlin; M Twilt
Journal:  Curr Rheumatol Rep       Date:  2017-11-04       Impact factor: 4.592

5.  Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results.

Authors:  Leslie A Favier; Janalee Taylor; Kristin Loiselle Rich; Karla B Jones; Sheetal S Vora; Julia G Harris; Beth S Gottlieb; Lisa Robbins; Jamie T Lai; Tzielan Lee; Melanie Kohlheim; Jennifer Gill; Laura Bouslaugh; Angela Young; Nancy Griffin; Esi M Morgan; Avani C Modi
Journal:  J Rheumatol       Date:  2018-02-01       Impact factor: 4.666

6.  Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease.

Authors:  Heikki Relas; Silja Kosola
Journal:  Clin Rheumatol       Date:  2018-10-29       Impact factor: 2.980

7.  Design and acceptance of Rheumates@Work, a combined internet-based and in person instruction model, an interactive, educational, and cognitive behavioral program for children with juvenile idiopathic arthritis.

Authors:  Wineke Armbrust; Joyce J F J Bos; Jeannette Cappon; Marion A J J van Rossum; Pieter J J Sauer; Nico Wulffraat; Veera K van Wijnen; Otto T H M Lelieveld
Journal:  Pediatr Rheumatol Online J       Date:  2015-07-23       Impact factor: 3.054

8.  Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and Caregivers.

Authors:  Daniel B Horton; Jomaira Salas; Aleksandra Wec; Melanie Kohlheim; Pooja Kapadia; Timothy Beukelman; Alexis Boneparth; Ky Haverkamp; Melissa L Mannion; L Nandini Moorthy; Sarah Ringold; Marsha Rosenthal
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-03       Impact factor: 4.794

9.  Reduced physical activity in children and adolescents with Juvenile Idiopathic Arthritis despite satisfactory control of inflammation.

Authors:  Anna-Helene Bohr; Susan Nielsen; Klaus Müller; Freddy Karup Pedersen; Lars Bo Andersen
Journal:  Pediatr Rheumatol Online J       Date:  2015-12-10       Impact factor: 3.054

10.  Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists.

Authors:  Wineke Armbrust; Jolanda G Kaak; Jelte Bouma; Otto T H M Lelieveld; Nico M Wulffraat; Pieter J J Sauer; Eric van Sonderen
Journal:  Pediatr Rheumatol Online J       Date:  2013-12-24       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.